Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
By Yan Zhang, M. Xiao, Shulan Zhang, P. Xia, W. Cao, Wei Jiang, Huan Chen, X. Ding, Hua Zhao, Hongmin Zhang and 25 more. New England Journal of Medicine, 2020
1,984 citations recorded by the source corpus.
Coagulopathy in Critical Illness with Covid-19 The authors describe a 69-year-old man with Covid-19 diagnosed in January 2020 in Wuhan, China, along with two other critically ill patients with Covid-19 who were also seen in the same intensive care unit. Coagulopathy and antiphospholipid antibodies were seen in all three patients.
Subfields: Dermatology, Infectious Diseases, Rheumatology
View Paper: https://www.semanticscholar.org/paper/39ea75fa66246138eb4f8bdfa8e466da1c66fe86
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Infectious Diseases
Citations in the corpus
- Neutrophil extracellular traps in COVID-19. (2020, background): “We identified a fourth patient who developed VTE several weeks into his hospitalization.”
- Coronavirus (COVID-19) (2020, background): “Coagulopathy associated with antiphospholipid antibodies and multiple infarcts have been reported in three elderly patients with COVID-19 infection and multiple comorbidities [74].”
- Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective, Single-Center, Clinicopathologic Case Series (2020, background): “Patients with severe COVID-19 can develop COVID-19–associated coagulopathy (CAC), with features of both disseminated intravascular coagulation and thrombotic microangiopathy, resulting in widespread microvascular thrombosis that may involve the liver (as in 1 of our patients) and consumption of coag”
- Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19 (2020, positive): “Recent studies found that patients with myocardial injury in hospitalization had a significantly higher in-hospital mortality rate than did those without myocardial injury (1,2).”